Previous 10 |
SAN DIEGO, March 25, 2019 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (VTL) announced today that Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) have both recommended that Vital Therapies stockholders vote “FOR” the proposed business c...
Goldman analyst Judy Hong downgrades Monster Beverage (NASDAQ: MNST ) to Neutral from Buy. Removes MNST from Goldman's Americas Conviction list. More news on: Monster Beverage Corporation, Vital Therapies, Inc., Quick stock ideas, Consumer stocks news, Read more ...
Vital Therapies (NASDAQ: VTL ): FY GAAP EPS of -$0.98 beats by $0.13. Cash and equivalents of $13.3M Press Release More news on: Vital Therapies, Inc., Earnings news and commentary, Healthcare stocks news, ,
SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company that has been developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the year ended December 31, 2018. R...
NEW YORK, NY / ACCESSWIRE / September 13, 2018 / Bausch Health Companies together with Salix's licensors Cedars-Sinai Medical Center and Alfasigma SpA resolve the outstanding intellectual property litigation with Actavis Laboratories. Vital Therapies’ shares dived deep in red followin...
Gainers: NMRD +47% . XBIT +27% . CIFS +23% . ARCI +18% . GLPG +17% . SLDB +17% . VVUS +15% . MHLD +15% . CDXC +14% . BHC +13% . More news on: Nemaura Medical, Inc., Xbiotech, China Internet Nationwide Financial Services Inc., Stocks on the move, , ...
VTL -89% as VTL-308 fails to achieve primary and secondary endpoints of improvement in survival. More news on: Vital Therapies, Inc., PolarityTE, Inc., Renren Inc., Stocks on the move, , Read more ...
Zealand Pharma A/S (NASDAQ: ZEAL ) resumed with Overweight rating at Morgan Stanley following its $205M deal with Royalty Pharma. More news on: Zealand Pharma, Intercept Pharmaceuticals, Vital Therapies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Vital Therapies (NASDAQ: VTL ) announces that, while there was a numerical improvement in survival in the ELAD-treated group between three months and one year following randomization, the VTL-308 study failed to meet the primary endpoint of a significant improvement in overall surviva...
News, Short Squeeze, Breakout and More Instantly...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into a non-binding Heads of Agreement with Hebei Visual Medical Technology Co. Ltd (HVMT), marking a significant step in VTL's distribution strategy into the market of the People'...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received human ethics approval from the Human Research Ethics Committee of The Peter MacCallum Cancer Centre for its Phase II cl...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has been advised by Invictus BioPharma Holdings Ltd (IVBHL) that IVBHL is now in a position to commence the process of acquiring Invictus BioPharma Pty Ltd in accordance with the Share Sale A...